Roivant Sciences ROIV
NASDAQ ROIV
$35.53 +0.03 (+0.09%)
As of: Oct 2, 2026 · 11:19 AM EDT

Roivant Sciences (ROIV) Accumulated Expenses (2021 - 2026)

Updated

Roivant Sciences' Accumulated Expenses came in at $168.74 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), up 90.2% from $88.73 million a year earlier but down 18.0% from the prior quarter.

Analysis

Roivant Sciences (ROIV) Accumulated Expenses (2021 - 2026) Analysis & Trends

At the end of FY2026 (ended Mar 31, 2026), Roivant Sciences' Accumulated Expenses was $205.82 million, up 80.1% from FY2025.

  • Accumulated Expenses carries a five-year compound annual growth rate of 21.8% (FY2021 to FY2026).
  • Going back by fiscal year, Accumulated Expenses was $114.29 million in FY2025 (-4.3%), $119.42 million in FY2024 (-28.5%), $167.13 million in FY2023 (+31.0%) and $127.53 million in FY2022 (+65.8%).
  • The five-year range for quarterly Accumulated Expenses is $88.73 million (fiscal Q1 2026) to $205.82 million (fiscal Q4 2026).
  • Year-over-year, Accumulated Expenses has increased for three consecutive quarters, with growth averaging 12.3% over the last eight quarters.
  • The fastest year-over-year change in Accumulated Expenses over five years came in fiscal Q1 2027 (growth of 90.2%), and the weakest in fiscal Q1 2026 (a decline of 35.8%).
  • Business Quant data shows ROIV's Accumulated Expenses at $205.82 million (Q4 2026), $117.99 million (Q3 2026) and $108.32 million (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Roivant Sciences 26.43 Bn 27.12 Bn 1.16 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 168.74 Mn
Mar 31, 2026 205.82 Mn
Dec 31, 2025 117.99 Mn
Sep 30, 2025 108.32 Mn
Jun 30, 2025 88.73 Mn
Mar 31, 2025 114.29 Mn
Dec 31, 2024 104.32 Mn
Sep 30, 2024 111.47 Mn
Jun 30, 2024 138.29 Mn
Mar 31, 2024 119.42 Mn
Dec 31, 2023 122.15 Mn
Sep 30, 2023 152.92 Mn
Jun 30, 2023 119.33 Mn
Mar 31, 2023 167.13 Mn
Dec 31, 2022 132.36 Mn
Sep 30, 2022 128.82 Mn
Jun 30, 2022 109.35 Mn
Mar 31, 2022 127.53 Mn
Dec 31, 2021 112.68 Mn
Sep 30, 2021 104.11 Mn
API Access

Roivant Sciences Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=ROIV&period=max&api_key=YOUR_API_KEY